FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ondansetron Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Gastroenterology

Expand all

Teva Pharmaceuticals (New 10/12/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
EQ 2MG BASE/ML, INJECTION, SOLUTION,20 mL Vials, (NDC 0703-7226-03) 10/12/2018 This was a business-related decision to discontinue manufacturing these products
EQ 2MG BASE/ML, INJECTION, SOLUTION, 20 mL Vial, (NDC 0703-7226-01) 10/12/2018 This was a business-related decision to discontinue manufacturing these products
EQ 2MG BASE/ML, INJECTION, SOLUTION, 2 mL Vial, (NDC 0703-7221-04) 10/12/2018 This was a business-related decision to discontinue manufacturing these products
EQ 2MG BASE/ML, INJECTION, SOLUTION, 2 mL Vial, (NDC 0703-7221-01) 10/12/2018 This was a business-related decision to discontinue manufacturing these products

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English